Sagimet Biosciences Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Sagimet Biosciences Inc. | SGMT - NASDAQ |
$15.00-$17.00 | $16.00 | $15.50 | 5.3 million | 7/14/2023 |
| Goldman Sachs, Cowen, Piper Sandler | ||||||
Co-Manager(s): JMP Securities
| ||||||
| Health Care | ||||||
Filing(s): 1st Filed 2021-04-16 Filed 2023-06-23 Terms Added 2023-07-10 | ||||||
Sagimet Biosciences Inc. Quote & Chart - Click for current quote - SGMT
IPO Boutique aggregates information on public companies and private companies, such as Sagimet Biosciences Inc. "SGMT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Sagimet Biosciences Inc. (adapted from Sagimet Biosciences Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing a portfolio of internally-discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of several diseases that result from the overproduction of the fatty acid, palmitate
This description is adapted from Sagimet Biosciences Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company focused on developing a portfolio of internally-discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of several diseases that result from the overproduction of the fatty acid, palmitate
This description is adapted from Sagimet Biosciences Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as Sagimet Biosciences Inc. "SGMT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.